Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

24-hour cardiovascular action and compliance

¹Department of Medicine, University Hospitals, Basel, Switzerland.

|January 1, 1992

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967).

Membrane & cell biology·2000

Same author

Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·1998

Same author

Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique.

The Biochemical journal·1996

Same author

Prevention of neointima formation by mibefradil after vascular injury in rats: comparison with ACE inhibition.

Cardiovascular drugs and therapy·1996

Same author

Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects.

Journal of vascular research·1995

Same author

Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.

Arteriosclerosis, thrombosis, and vascular biology·1995